Novartis faces whistleblower claims of bribery in Turkey

Novartis ($NVS) faces bribery allegations in yet another country. A whistleblower has accused the Swiss drugmaker of paying bribes in Turkey to increase prescriptions of its drugs, Reuters reports. More from FiercePharma

Suggested Articles

opdivo
Marketing

BMS, on a roll, touts 2 Opdivo GI cancer wins

Opdivo's wins in front-line gastric and esophageal cancers comes a year after Merck's Keytruda flopped in the same setting.

by Angus Liu
Actor Tony Hale at the Streamy Awards
Marketing

AZ promotes asthma blood test with spokesceleb Tony Hale

AstraZeneca partners with actor and asthma sufferer Tony Hale to raise awareness about eosinophilic asthma and blood testing to diagnose it.

by Beth Snyder Bulik
voice recognition for mobile phones
Marketing

Pharma video ads surge after initial COVID-19 slowdown

Pharma video ads have bounced back after initial COVID-19 shelter-in-place advice and uncertainty dampened placements.

by Beth Snyder Bulik